cell.com
Fc-optimized CD40 agonistic antibody elicits tertiary lymphoid structure formation and systemic antitumor immunity in metastatic cancer
Osorio et al. report a first-in-human study of intratumoral 2141-V11, an Fc-engineered
CD40 agonistic antibody, showing it is safe and induces systemic and durable antitumor
immunity in patients with ...